Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

UK approves Covid vaccines for babies as young as six months could soon get Pfizer jab

Britain's health regulator has today authorised the Pfizer vaccine for infants as young as six months, as the decision opens the door for advisers to choose whether the jab should be given to under-fives

Daily Mirror

Covid: UK health regulator backs Pfizer/BioNTech vaccine for babies as young as six months

The move opens the door to vaccinating the country’s youngest children should the Joint Committee on Vaccination and Immunisation agree

Evening Standard

The business of clinical trials is booming. Private equity has taken notice

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer to invest $750M in Kalamazoo area facility, add hundreds of new jobs

LANSING, Michigan— Pharmaceutical giant Pfizer Inc. will invest $750 million in its southwest Michigan facility to increase capacity for manufacturing sterile injectable medications, creating 300 new jobs, the company announced Monday.

Tribune News Service

Pfizer asks FDA to clear updated COVID shot for kids under 5

Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5

The Independent UK

‘Bonkers’ Covid plans, Boris’ vaccine dance and post-affair ‘misery’: 13 bombshells from Matt Hancock’s memoir

The former health secretary’s diaries lay the blame squarely on everyone — except himself and new partner Gina Coladangelo. Katie Strick picks his standout quotes from the extracts released so far

Evening Standard

5 Amazing Stocks You Won’t Ever Regret Buying

Easing inflation and the Fed’s indication of slowing the pace of interest rate hikes are raising investors’ sentiments. Moreover, the November job report came in better than expected. While uncertainties remain, we think quality stocks Pfizer (PFE), AstraZeneca PLC (AZN), Carrier Global (CARR), J. Jill (JILL), and Lifeway Foods (LWAY)…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

China dumping its draconian ‘zero COVID’ policy could come at the huge cost of rampant infections: 'This will spread like wildfire'

The end result could be “hundreds of millions” of infected Chinese, Dr. Ali Mokdad, a professor at the University of Washington’s Institute for Health Metrics and Evaluation, said.

Fortune

Will A Pfizer-Partnered Vaccine Help Valneva Stock Buck Its Recent Downtrend?

Valneva stock rose Thursday after it said volunteers who received its Pfizer-partnered Lyme disease shot still had antibodies after six months.

Investors Business Daily

Pfizer to create over 400 new Dublin with jobs €1.2 billion expansion

The company employs over 5,000 people in Ireland

Dublin Live

3 Stocks That Still Have Room to Run

With the October inflation report showing signs of cooling and anticipations of a slowdown in interest rate hikes, the stock market looks poised to extend its recent rally. Hence, it could be wise to invest in fundamentally sound stocks Pfizer (PFE), Cisco Systems (CSCO), and Raytheon Technologies (RTX) that still…

StockNews.com

Doctors admit Covid vaccine possibly linked to 'mystery' death of Longford woman

Ms Brady told the inquest her family had found it 'very insulting and upsetting' that her mother had been described as 'a mystery patient' at the hospital in Mullingar because nobody had any answers about what was causing her illness.

Irish Mirror

1 High-Dividend Stock to Add to Your Portfolio if You Haven’t Already

Amid prevalent COVID-19 cases, vaccine pioneer Pfizer (PFE) is significantly benefiting. Moreover, the company beat wall street expectations in the third quarter with a robust financial result and raised its revenue and EPS guidance for the year. Given its strong fundamentals, the stock could be a wise addition to your…

StockNews.com

Universal flu vaccine could be ready for human use in two years – expert

The US researchers have created a vaccine based on the same mRNA technology used in the Covid-19 jabs from Moderna and Pfizer.

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Chicago Sun-Times

COVID risk could rise again as federal funding drains, Chicago’s top doc warns

The city will soon lose hundreds of millions of dollars in public health funding as federal pandemic aid runs out. That, combined with low booster shot participation, could spell another surge in COVID, Dr. Allison Arwady says.

Reuters

Researchers test mRNA technology for universal flu vaccine

An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent future pandemics, according to a U.S. study published on Thursday.

StockNews.com

3 Strong Buy Stocks to Continue to Hold Onto in 2023

As the Fed’s aggressive monetary policy resulted in slightly cooled inflation last month, investors are hopeful of smaller rate hikes ahead. However, since a recession is expected to hit the economy next year, we think fundamentally sound stocks Pfizer (PFE), Flowers Foods (FLO), and Xperi (XPER), which are rated Strong…

Wales Online

Boy, 14, died three weeks after having Covid vaccine

A coroner has said there will be a 'considerable investigation'

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

US renews push for COVID boosters as data show they protect

Americans who have gotten the updated COVID-19 boosters appear better protected against symptomatic infection than those who haven't — at least for now

Daily Mirror

Death of boy, 14, three weeks after Covid jab of 'significant public concern' - coroner

Joseph McGinty died at home on Achill Island in County Mayo, Ireland, three weeks after receiving the Pfizer Covid-19 jab, with a coroner describing the death as a "significant public concern"

The Conversation

Intellectual property waiver for COVID vaccines should be expanded to include treatments and tests

Global inequities in access to COVID vaccines have turned out to be a “catastrophic moral failure”, just as the World Health Organization warned they would in January 2021. Yet it took 20 months of negotiations for members of the World Trade Organization (WTO) to agree to a limited relaxation of…

The Conversation

RSV: experts explain why rates of this virus are surging this year

Respiratory syncytial virus (RSV) is a very common virus, typically causing infection in children during the colder months. In most cases, RSV causes a mild illness, with symptoms similar to that of a regular cold.

Tribune News Service

Elizabeth Holmes: What convictions and acquittals led up to her sentencing

Theranos founder Elizabeth Holmes walked into her criminal trial in federal court in San Jose in September 2021 charged with 12 counts of fraud in connection with her now-defunct Palo Alto blood-testing startup. Four months later, she walked out guilty on four counts, after a jury found her liable for…

The Independent UK

Pfizer booster spurs immune response to new omicron subtypes

Pfizer said its updated COVID-19 booster may offer some protection against newly emerging omicron mutants even though it’s not an exact match

Reuters

Pfizer/BioNTech's updated COVID shot shows strong response against BQ.1.1

Pfizer Inc and its German partner BioNTech SE said on Friday their Omicron-tailored shot produced higher virus-neutralizing antibodies in older adults against the emerging subvariant BQ.1.1 than its original vaccine.

1 … 26 27 28 29

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.